Please login to the form below

Not currently logged in
Email:
Password:

Senior changes at EMA

New head of IT and chair of committee for advanced therapies
EMA Dina Tsiambaou

The European Medicines Agency (EMA) has announced changes in leadership for both its IT division and its Committee for Advanced Therapies (CAT).

Dina Tsiambaou (pictured) joins the Agency, which regulates medicines in the EU, as head of the IT development department. She was previously a senior manager in IT at management consultancy Accenture.

In this role she gained experience working in a number of regions, including China, Mauritius, Thailand, Singapore, Turkey, the US, Germany and Ireland.

The EMA's other new appointment was that of Dr Paula Salmikangas as chair of the CAT, the EMA committee responsible for assessing the quality, safety and efficacy of advanced-therapy medicinal products.

She was previously vice-chair of the committee and succeeds Christian Schneider, who had chaired the CAT since its creation in 2009.

In addition to her EMA role, Dr Salmikangas is a senior research at the Finnish Medicines Agency.

18th February 2014

From: Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Atlantis Healthcare

Atlantis Healthcare is a global leader in optimising patient self-management. Established in 1996, we design, develop and implement scalable solutions...

Latest intelligence

A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....
The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....

Infographics